GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » YSB Inc (HKSE:09885) » Definitions » EV-to-Revenue

YSB (HKSE:09885) EV-to-Revenue : 0.19 (As of Jun. 23, 2024)


View and export this data going back to 2023. Start your Free Trial

What is YSB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, YSB's enterprise value is HK$3,482 Mil. YSB's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$18,564 Mil. Therefore, YSB's EV-to-Revenue for today is 0.19.

The historical rank and industry rank for YSB's EV-to-Revenue or its related term are showing as below:

HKSE:09885' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.04   Med: 0.2   Max: 2.34
Current: 0.19

During the past 4 years, the highest EV-to-Revenue of YSB was 2.34. The lowest was 0.04. And the median was 0.20.

HKSE:09885's EV-to-Revenue is ranked better than
94.32% of 669 companies
in the Healthcare Providers & Services industry
Industry Median: 1.77 vs HKSE:09885: 0.19

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-23), YSB's stock price is HK$8.15. YSB's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$80.56. Therefore, YSB's PS Ratio for today is 0.10.


YSB EV-to-Revenue Historical Data

The historical data trend for YSB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YSB EV-to-Revenue Chart

YSB Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
- - - 0.19

YSB Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial - - - - 0.19

Competitive Comparison of YSB's EV-to-Revenue

For the Pharmaceutical Retailers subindustry, YSB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YSB's EV-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, YSB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where YSB's EV-to-Revenue falls into.



YSB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

YSB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=3481.704/18563.93
=0.19

YSB's current Enterprise Value is HK$3,482 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. YSB's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$18,564 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


YSB  (HKSE:09885) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

YSB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=8.15/80.557
=0.10

YSB's share price for today is HK$8.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$80.56.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


YSB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of YSB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


YSB (HKSE:09885) Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Brand Street, No. 397 Xingang Middle Road, Yaoshibang Building, TIT Creative Industry Zone, Guangzhou, CHN
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The Company is committed to using digitalization to empower participants in the out-of-hospital pharmaceutical market, including pharmaceutical companies, distributors, vendors, pharmacies and primary healthcare institutions, and strives to bring pharmaceutical health products and services to the downstream safely and efficiently, so that users can easily obtain a large number of comprehensive and high-quality drugs at a fair and transparent price. It has turned the process of pharmaceutical transaction and service into a digitalized, standardized and scalable one.
Executives
Chu Mang Yee 2201 Interest of corporation controlled by you
Meta Group Limited 2201 Interest of corporation controlled by you
Sounda Properties Limited 2201 Interest of corporation controlled by you
Shenzhen Songhe International Capital Management Partnership (limited Partnership) 2201 Interest of corporation controlled by you
Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd. 2101 Beneficial owner
Shanghai Fosun Pharmaceutical (group) Co., Ltd. 2201 Interest of corporation controlled by you
Shanghai Fosun High Technology (group) Co., Ltd. 2201 Interest of corporation controlled by you
Chen Xiaohong 2201 Interest of corporation controlled by you
H Capital V Gp, L.p. 2201 Interest of corporation controlled by you
H Capital V Gp, Ltd. 2201 Interest of corporation controlled by you
Guo Guangchang 2201 Interest of corporation controlled by you
Fosun Holdings Limited 2201 Interest of corporation controlled by you
Fosun International Holdings Ltd. 2201 Interest of corporation controlled by you
Fosun International Limited 2201 Interest of corporation controlled by you
Miyt Holdings Limited 2101 Beneficial owner

YSB (HKSE:09885) Headlines

No Headlines